APRIL NEELY: Open Payments
NPI 1366884793 · BLUEFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 100 payments from 10 companies in 2025. Trend: 2023 $1,157 · 2024 $1,896 · 2025 $1,405
Food & beverage: $1,344Education: $61
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 43 | $391 |
| ABBVIE INC. | 19 | $366 |
| UCB, Inc. | 19 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $96 |
| Amgen Inc. | 5 | $90 |
| GENZYME CORPORATION | 3 | $60 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Organogenesis Inc. | 1 | $25 |
Products named: TREMFYA, SKYRIZI, Bimzelx, RINVOQ, OTEZLA, DUPIXENT, TALTZ, CIBINQO.
Industry payments across VA — which companies pay providers there.
